🇺🇸 FDA
Pipeline program

YAZ (SH T00186, BAY86-5300)

91619

Phase 3 small_molecule completed

Quick answer

YAZ (SH T00186, BAY86-5300) for Contraception is a Phase 3 program (small_molecule) at Bayer HealthCare AG with 1 ClinicalTrials.gov record(s).

Program details

Company
Bayer HealthCare AG
Indication
Contraception
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials